11 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 0.8% per year over the past 5 years.
Financial health
Total debt ($368M) exceeds cash ($145M); net debt is $223M.
Total debt has grown slower than revenue (-4.2% vs 0.8% per year).
Operating income covered interest expense -0.8× in the latest year.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$845M
-$70M
34.4%
-3.3%
$19M
$368M
$145M
2024
$811M
-$49M
31.7%
4.0%
$20M
$443M
$169M
2023
$893M
$47M
32.5%
8.6%
$88M
$443M
$153M
2022
$859M
$30M
33.0%
10.3%
-$4M
$414M
$89M
2021
$818M
$17M
33.2%
9.1%
$78M
$435M
$145M
2020
—
-$58M
—
—
-$10M
$455M
$101M
2019
—
$16M
—
—
$52M
$395M
$30M
2018
—
$28M
—
—
$65M
$390M
$52M
2017
—
$52M
—
—
$55M
$484M
$83M
2016
—
$69M
—
—
$45M
$0
$37M
2015
—
$80M
—
—
$51M
—
$21M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Apr '26
$216M
-$8M
33.6%
6.7%
-$8M
$348M
$85M
Jan '26
$210M
$2M
33.3%
7.3%
-$27M
$368M
$120M
Oct '25
$229M
$12M
34.0%
8.6%
$2M
$368M
$145M
Jul '25
$203M
-$89M
33.3%
-39.8%
$1M
$368M
$136M
Apr '25
$213M
$7M
36.0%
10.4%
$10M
$567M
$205M
Jan '25
$200M
-$300000
34.3%
5.6%
$5M
$567M
$176M
Sep '24
$206M
-$51M
32.6%
5.3%
$20M
$443M
$169M
Jun '24
$209M
$1M
32.0%
4.4%
$3M
$443M
$156M
Mar '24
$206M
$1M
31.9%
3.7%
-$3M
$443M
$142M
Dec '23
$190M
-$500000
30.1%
2.2%
-$100000
$443M
$141M
Sep '23
$227M
$32M
34.3%
10.7%
$42M
$443M
$153M
Jun '23
$232M
$9M
32.9%
10.4%
$34M
$443M
$119M
Mar '23
$228M
$4M
31.9%
6.8%
$22M
$443M
$104M
Dec '22
$206M
$3M
30.8%
6.3%
-$9M
$443M
$82M
Sep '22
$231M
$13M
32.2%
10.6%
$7M
$414M
$89M
Jul '22
$215M
$8M
34.2%
10.7%
-$7M
$413M
$100M
Apr '22
$215M
$8M
33.0%
12.4%
-$12M
$411M
$115M
Dec '21
$199M
$1M
32.6%
7.0%
$7M
$437M
$158M
Oct '21
—
$9M
—
—
$48M
$435M
$145M
Jul '21
$211M
$12M
35.1%
12.2%
$17M
$463M
$128M
Valuation over time
How the market has priced VREX against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 25.3× (Mar '23) to 11.1× (Aug '24).
The price-to-sales ratio has fallen from 0.9× (Mar '23) to 0.5× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is VREX growing its revenue and profit?
Over the past 5 years, Varex Imaging Corp's revenue has grown 0.8% per year. These are computed facts, not advice.
How much debt does VREX have?
As of FY2025, Varex Imaging Corp reported $368M of total debt against $145M of cash; operating income covered interest expense -0.8×.
What is VREX's profit margin?
In FY2025, gross margin was 34.4%, operating margin -3.3%, and net margin -8.3%.
What is VREX's P/E ratio?
As of Jun '26, Varex Imaging Corp traded at a price-to-earnings ratio of about 11.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.